ARCHIVES

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Harold Amos Receives Drew Medical Prize

October 27, 1989

FDA Oncologic Drug Committee Agrees That “Kitty Fight” With NCI Should Be Negotiated

November 28, 1975

Science Policy: Increased Cancer Death Rate For Atomic Vets Not Significant, OIM Says

October 29, 1999

Barnett Kramer Retires From NIH

January 7, 2011

NCI Considering Combining Support, Control Core Grants; Directors Reject Two Grants, One Review

June 2, 1978

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008